Active Ingredient: TIGECYCLINE
Proprietary Name: TIGECYCLINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205722
Product Number: 001
Approval Date: Oct 18, 2019
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Discontinued
Patent and Exclusivity Information